Marchetti G, Amaducci L, Faravelli C, Matteini P, Pazzagli A
Riv Patol Nerv Ment. 1977 Mar-Apr;98(2):88-98.
Fourty in-patients suffering from depressive illness were treated with a new antidepressant drug, viloxazine. Apart from the already well-established antidepressant action, the authors emphasize the lack of anticholinergic effects; this illnesses with organic damage where usual antidepressant therapy is contraindicated
40名患有抑郁症的住院患者接受了一种新型抗抑郁药物维洛沙嗪的治疗。除了已被充分证实的抗抑郁作用外,作者强调该药物缺乏抗胆碱能作用;对于有器质性损害且常规抗抑郁治疗禁忌的疾病。
需注意,原文中“Fourty”拼写错误,应为“Forty” 。